Aneta Szczerkowska-Dobosz
Overview
Explore the profile of Aneta Szczerkowska-Dobosz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
425
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Purzycka-Bohdan D, Szczerkowska-Dobosz A, Szczypior M, Nowicki R
Postepy Dermatol Alergol
. 2022 Sep;
39(4):821-822.
PMID: 36090710
No abstract available.
12.
Kisielnicka A, Sobalska-Kwapis M, Purzycka-Bohdan D, Nedoszytko B, Zablotna M, Seweryn M, et al.
Int J Mol Sci
. 2022 Jul;
23(13).
PMID: 35806402
There is evidence that the concomitance of psoriasis and obesity may originate from the interplay between multiple genetic pathways and involve gene−gene interactions. The aim of this study was to...
13.
Kisielnicka A, Szczerkowska-Dobosz A, Purzycka-Bohdan D, Nowicki R
Postepy Dermatol Alergol
. 2022 Jun;
39(2):251-257.
PMID: 35645673
Hyperhidrosis is a disorder of sweat glands characterized by overproduction of sweat, which is inadequate to the thermoregulatory needs of the body system. Owing to the heavy social and economic...
14.
Rogowska P, Walczak P, Wrzosek-Dobrzyniecka K, Nowicki R, Szczerkowska-Dobosz A
Clin Cosmet Investig Dermatol
. 2022 Apr;
15:587-593.
PMID: 35418768
Purpose: Among populations of Western countries, tattoos have become an accepted form of skin ornamenting. With tattoos growing in popularity, also patients suffering from chronic dermatoses may more often be...
15.
Roter G, Szczerkowska-Dobosz A, Nowicki R
Lasers Surg Med
. 2022 Mar;
54(5):688-692.
PMID: 35289430
Background And Objectives: There are limited treatment options for nail psoriasis. It is important to find new therapies and improve existing ones. The aim of this study was to compare...
16.
Purzycka-Bohdan D, Kisielnicka A, Zablotna M, Nedoszytko B, Nowicki R, Reich A, et al.
J Clin Med
. 2022 Mar;
11(5).
PMID: 35268344
The epidemiology of psoriasis has not been widely assessed in Polish population so far. This study aimed to investigate psoriasis epidemiological situation by evaluating disease course and severity, management, comorbidities,...
17.
Dobosz M, Rogowska P, Sokolowska E, Szczerkowska-Dobosz A
J Cosmet Dermatol
. 2022 Mar;
21(10):4646-4650.
PMID: 35243745
Background: Motivations for getting aesthetic medicine treatments concern not only the improvement of the physical appearance but also internal aspects such as feeling more confident or happier. Body dysmorphic disorder...
18.
Rogowska P, Sobjanek M, Slawinska M, Nowicki R, Szczerkowska-Dobosz A
Dermatology
. 2021 Dec;
238(4):799-806.
PMID: 34969030
Background: The frequency of tattoos varies from 10% to 30% across the population worldwide. The growing popularity of tattooing increases the number of cutaneous reactions connected with this procedure. As...
19.
Wierzbicka J, Piotrowska A, Purzycka-Bohdan D, Olszewska A, Nowak J, Szczerkowska-Dobosz A, et al.
Int J Mol Sci
. 2021 Dec;
22(23).
PMID: 34884710
Interleukin 33 (IL-33) belongs to the IL-1 family and is produced constitutively by epithelial and endothelial cells of various organs, such as the skin. It takes part in the maintenance...
20.
Purzycka-Bohdan D, Glen J, Zablotna M, Nedoszytko B, Szczerkowska-Dobosz A, Sokolowska-Wojdylo M, et al.
Postepy Dermatol Alergol
. 2021 Oct;
38(4):657-664.
PMID: 34658710
Introduction: Interleukin-31 (IL-31) impact on the development and clinical presentation of psoriasis as well as pruritus has not been widely investigated so far. Aim: To analyse IL-31 -1066G/A and -2057G/A...